BiolMed Innovations

• BiolMed is a technology start-up that leverages materials science of natural silk proteins to develop and sell biomedical implants and tissue regeneration products.
• BiolMed has access to unique intellectual property from India’s premier  research lab in materials science, CSIR-National Chemical Laboratory. IP is  relating to designing, structuring and tailoring silk-based materials.
• BiolMed’s founders are experienced biomed technology developers with  backgrounds from IIT, UDCT, Delaware, Cambridge, MIT and GE.

BiolMed receives the DBT-BIRAC-BIPP grant funding

Feb 2018: Biotechnology Industry Research Assistance Council (BIRAC) approved the BIPP funding for the flagship product of BiolMed - Serioss. The funding approved is to the tune of 1.5 Cr. The funding will accelerate the product development path for Serioss. 

BIRAC awards SBIRI grant to BiolMed Innovations

Feb 2017: Biotechnology Industry Research Assistance Council (BIRAC) approved the funding for SBIRI for the second product that the company is developing. The company was approved funding of ₹ 24.96 Lakhs. The funding will support the development of a composite matrix for soft tissue reconstruction.

BiolMed wins the prestigious Biotechnology Ignition Grant from DBT-BIRAC

June 2015: Biotechnology Industry Research Assistance Council (BIRAC) approved the funding for BiolMed Innovations in the fourth round for the Biotechnology Ignition Grant (BIG). The company was approved funding of ₹ 49.26 Lakhs. The funding will support the initial set up for the first product development for BiolMed.